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Abstract
The replication of Tropheryma whipplei (the agent of Whipple’s disease) within human macrophages is associated with the
expression of IL-16, a cytokine known for its chemotactic and inflammatory properties. In this study, we asked whether IL-16
acts on T. whipplei replication by interfering with the endocytic pathway. We observed that in macrophages, T. whipplei was
located within late phagosomes that were unable to fuse with lysosomes; in monocytes, T. whipplei was eliminated in
phagolysosomes. Moreover, adding IL-16 to monocytes induced bacterial replication and inhibited phagolysosome
formation. On the other hand, blocking IL-16 activity, either with anti-IL-16 antibodies in human macrophages or by using
murine IL-16
2/2 bone marrow-derived macrophages, inhibited T. whipplei replication and rescued phagolysosome
biogenesis. Furthermore, we propose that IL-16-mediated interference with the endocytic pathway is likely related to
macrophage activation. First, IFNc induced T. whipplei elimination and phagolysosome formation and inhibited IL-16
production by macrophages. Second, the full transcriptional response of murine macrophages to T. whipplei showed that T.
whipplei specifically modulated the expression of 231 probes in IL-16
2/2 macrophages. Gene Ontology analysis revealed
that 10 of 13 over-represented terms were linked to immune responses, including proinflammatory transcriptional factors of
the NF-kB family. Our results demonstrated a previously unreported function for IL-16 in promoting bacterial replication
through inhibited phagolysosome biogenesis and modulated macrophage activation program.
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Introduction
Whipple’s disease (WD) is a chronic multisystemic infection
caused by Tropheryma whipplei [1]. The classical manifestations of
WD are weight loss, diarrhea, polyarthralgia, fever, and
lymphadenopathy. In addition, cardiac and central nervous
system symptoms may also be associated with WD [2]. The
course of WD is fatal unless antibiotic treatment is initiated [3].
Specific immune deficiencies and genetic traits have been
suggested to be involved in WD development. Indeed, impaired
interferon (IFN) c production associated with interleukin (IL)-12
deficiency and Th2 repolarization of the immune response has
been considered to be critical for WD physiopathology [2,4].
Consistent with these observations, we previously found that
macrophages from intestinal lesions are polarized into alternatively
activated macrophages, also known as M2 macrophages [5].
Furthermore, we have shown that T. whipplei replication in human
macrophages is related to IL-16 production [6]. IL-16, constitu-
tively produced as cytosolic pro-IL-16, is secreted after caspase-3-
mediated processing [7,8,9] by numerous cell types [10,11,12]. IL-
16 is a chemoattractant for CD4-expressing immune cells, such as
T cells [10], monocytes [13], dendritic cells [14] and eosinophils
[15]. Aside from its role as a chemoattractant, IL-16 may also be
involved in the innate immune response because it favors the
production of inflammatory cytokines by monocytes [16] and may
act on antigen-presenting cells as well [17]. IL-16 is also known to
modulate the adaptive immune response by favoring Th1
responses. Indeed, IL-16 primes T cells to IL-15 production and
CD25 expression, and thus renders them more susceptible to the
presence of IL-2 [18].
One of the microbicidal mechanisms of macrophages is based
on the formation of phagolysosomes. Specifically, macrophages
internalize microorganisms into phagosomes, which undergo
extensive remodeling involving an active exchange of material
with plasma membrane, endosomes, lysosomes, Golgi- and
endoplasmic-derived vesicles. Phagosomes fuse with early endo-
somes and then with late endosomes, as demonstrated by the
acquisition of specific markers such as early endosome antigen-1,
the small GTPases Rab5 and Rab7, and lysosome-associated
membrane protein (Lamp)-1, respectively. Finally, late phago-
somes fuse with lysosomes and acquire hydrolase enzymes such as
cathepsin D [19]. Microorganisms are destroyed in these
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cathepsin D [20]. However, several types of pathogenic microor-
ganisms have been shown to manipulate host cell organelles and
membrane trafficking processes to survive and replicate within
host cells [21,22]. For example, Salmonella resides in an atypical
phagosome that is neither an early nor a late phagosome [23].
Mycobacterium-containing phagosomes fuse with early endosomes
but are unable to fuse with late endosomes [24,25]. Coxiella burnetii,
the agent of Q fever, survives in macrophages within an acidic late
phagosome that does not fuse with lysosomes [26].
It is well-established that the microbicidal activity of mono-
cytes/macrophages is regulated by cytokines that polarize
macrophages [27]. IFNc, a cytokine known to confer microbicidal
competence to macrophages, controls Listeria monocytogenes infection
and its clearance [28]. However, only a few reports have
attempted to address the relationship between cytokines and
phagosome conversion. It has been shown that treatment of
macrophages with IFNc allows the elimination of mycobacteria
through the conversion of bacterial phagosomes to phagolyso-
somes [29,30]. IFNc triggers the listericidal competence of
macrophages by up-regulating the small GTPase activity required
for phagosome conversion [31]. IFNc stimulates C. burnetii
elimination and induces the maturation of C. burnetii phagosomes
in phagolysosomes [26]. Conversely, IL-10, an immunosuppres-
sive cytokine, promotes the intracellular localization of mycobac-
teria within phagosomes that are unable to fuse with lysosomes
[29] and stimulates C. burnetii replication by increasing the ability
of C. burnetii to traffic into an acidified late phagosome [32,33].
We have previously shown that T. whipplei is localized within an
acidic compartment associated with Lamp-1 unable to fuse with
lysosomes [34] and that T. whipplei replication in human
macrophages is related to IL-16 production [6]. However, the
mechanisms triggered by IL-16 that affect the intracellular fate of
T. whipplei remain largely understudied. In this study, we found
that IL-16 was required for T. whipplei replication within late
phagosomes in both human and murine macrophages. The lack of
IL-16 led to T. whipplei elimination within phagolysosomes. The
effect of IL-16 on T. whipplei replication in late phagosomes was
repressed by inhibiting IL-16 production by IFNc. Microarray
analysis of IL-16
2/2 macrophages indicated roles for IL-16 in the
innate immune response and the NF-kB pathway. Taken together,
our study demonstrates novel functions of IL-16 in intracellular
trafficking and macrophage regulation.
Results
Intracellular localization of T. whipplei
In the first series of experiments, human monocytes and
macrophages were infected with T. whipplei (50 bacteria/cell) for
four hours (designated as day 0) and washed to discard
unphagocytosed bacteria. The intracellular fate of T. whipplei
was assessed for 12 days. As published before [6], monocytes
eliminated T. whipplei, whereas T. whipplei replicated within
macrophages after a transient phase of T. whipplei elimination
(Figure 1).
We next studied the nature of the T. whipplei-containing
compartments in both monocytes and macrophages. In mono-
cytes, T. whipplei was eliminated within phagolysosomes that
acquired both Lamp-1 and cathepsin D. Specifically, 6263% of T.
whipplei phagosomes colocalized with Lamp-1, and 4768%
colocalized with cathepsin D at day 0. These percentages
increased to 80% at day 1, and intact bacteria were no longer
detected thereafter (Figure 2A). In macrophages, bacteria were
located in late phagosomes. Specifically, 2868% of T. whipplei
phagosomes were positive for Lamp-1 at day 0; this percentage
increased to 7169% and 9466% after 3 and 12 days, respectively.
In a first phase, T. whipplei colocalized with cathepsin D
(Figure 2B): 3365% of bacteria colocalized with cathepsin D
at day 0, and 3768% colocalized with it at day 1, suggesting that
bacteria were transiently eliminated within phagolysosomes. This
phenomenon might be related to the dramatic decrease in the T.
whipplei DNA copy number observed between day 0 and 3
(Figure 1). In a second phase (day 3–12), the percentage of T.
whipplei colocalizing with cathepsin D steadily decreased: at day
12, it was only 1164% (Figure 2B). This phenomenon might be
related to the increase in the T. whipplei DNA copy number
observed between days 3 and 12 (Figure 1). Taken together, these
results suggest that T. whipplei replication in macrophages is
associated with the presence of bacteria within late phagosomes
that are unable to fuse with lysosomes.
Effect of IL-16 on T. whipplei localization
Given that IL-16 release is related to T. whipplei replication [6],
we asked if exogenous IL-16 inhibits the conversion of T. whipplei
phagosomes to phagolysosomes. To address this question,
monocytes were treated for 16 hours with 10 ng/ml of recombi-
nant human (rh) IL-16 prior to T. whipplei infection [6]. The
pretreatment of monocytes with IL-16 did not significantly alter
bacterial uptake (Figure 3A, inset). T. whipplei replication
occurred to an extent similar to that observed in macrophages
(comparison between Figure 3A and Figure 1) as published
before [6]. However, T. whipplei colocalized with Lamp-1 but not
with cathepsin D in IL-16-treated monocytes (Figure 3B). The
percentage of phagosomes containing T. whipplei colocalizing with
cathepsin D fell significantly (p,0.05) (two-fold) between days 0
and 1. At day 12, T. whipplei was only present in IL-16-treated
cells, in which it resided in phagosomes associated with Lamp-1,
but not with cathepsin D (Figure 3C). We also studied the effect
of exogenous IL-16 on the intracellular fate of T. whipplei in
macrophages. IL-16 did not affect T. whipplei uptake but it
significantly (p,0.05) increased bacterial replication (Figure 4A)
as published before [6]. It also inhibited the acquisition of
Figure 1. T. whipplei replicates in macrophages but not in
monocytes. Monocytes and macrophages were incubated with T.
whipplei for four hours (50 bacteria/cell), washed to discard unphago-
cytosed bacteria and incubated for different time periods. Bacterial
uptake and replication were assessed by determining the bacterial DNA
copy number by qPCR. The results are expressed as the mean 6 SEM of
four experiments performed in triplicate.
doi:10.1371/journal.pone.0013561.g001
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PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13561Figure 2. T. whipplei localization in monocytes and macrophages. The intracellular localization of T. whipplei within monocytes at day 1 (A)
and macrophages at day 12 (B) was assessed by indirect immunofluorescence and laser scanning microscopy. Scale bars represent 5 mm. The
percentages of T. whipplei that colocalized with cathepsin D or Lamp-1 in monocytes (A) and macrophages (B) were determined. More than 300
phagosomes were examined per experimental condition, and the results are expressed as the mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0013561.g002
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PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13561Figure 3. Effect of exogenous IL-16 on T. whipplei fate in monocytes. Monocytes were treated with or without IL-16 for 18 hours, incubated
with T. whipplei for four hours (50 bacteria/cell), washed to remove unphagocytosed bacteria and incubated for additional time periods. (A) T.
whipplei uptake (inset) and replication were assessed by determining the bacterial DNA copy number by qPCR after 9 and 12 days of infection. The
results are expressed as the mean 6 SEM of four experiments performed in triplicate. (B) The intracellular localization of T. whipplei within IL-16-
treated monocytes was assessed by indirect immunofluorescence and laser scanning microscopy at day 12. Scale bars represent 5 mm. (C) The
percentages of T. whipplei that colocalized with cathepsin D or Lamp-1, respectively, were determined (n=5). More than 300 phagosomes were
examined per experimental condition, and the results are expressed as the mean 6 SEM of five independent experiments. p,0.05.
doi:10.1371/journal.pone.0013561.g003
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PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13561Figure 4. Effect of exogenous IL-16 on T. whipplei fate in macrophages. Macrophages were treated with rhIL-16 as described in Figure 3. (A)
T. whipplei uptake (inset) and replication were determined by qPCR. The results are expressed as the mean 6 SEM of four independent experiments
performed in triplicate. (B) The intracellular localization of T. whipplei was analyzed by indirect immunofluorescence and laser scanning microscopy at
day 12. Scale bars represent 5 mm. (C) The percentage of organisms that colocalized with Lamp-1 or cathepsin D, respectively, was determined. More
than 300 phagosomes were examined per experimental condition, and the results are expressed as the mean 6 SEM of four independent
experiments. p,0.05. (D) The localization of organisms with p62, a specific marker for autophagosomes, was assessed by indirect
immunofluorescence and laser scanning microscopy. More than 200 phagosomes were examined in two independent experiments.
doi:10.1371/journal.pone.0013561.g004
IL-16 and Phagosome Maturation
PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13561cathepsin D by T. whipplei phagosomes (Figure 4, B and C).
Next, we wondered whether IL-16 re-routed T. whipplei phago-
somes towards the autophagosome pathway. We found that Ab
directed against p62, a marker for autophagosomes [35], did not
colocalize with T. whipplei (Figure 4D). Finally, we investigated if
the effect of IL-16 on T. whipplei trafficking was specific using latex
beads. Latex beads were located within phagolysosomes at days 1
and 12 post-ingestion. IL-16 did not modify the latex beads
localization with either of the two markers (Figure S1),
demonstrating that IL-16 specifically acted on T. whipplei
trafficking. Taken together, these data show that incubating
monocytes or macrophages with exogenous IL-16 can increase T.
whipplei replication within phagosomes that are unable to be
converted to phagolysosomes.
Inhibition or absence of IL-16 rescued the maturation of
T. whipplei phagosomes
We then investigated the effect of IL-16 inhibition on the
replication and localization of T. whipplei in macrophages.
Treatment of macrophages with anti-IL-16 antibodies (Abs) did
not alter T. whipplei uptake but it dramatically inhibited bacterial
replication (Figure 5A) as published before [6]. It also induced the
conversion of T. whipplei phagosomes to phagolysosomes
(Figure 5B). Specifically, about 80% of T. whipplei phagosomes
colocalized with Lamp-1 and cathepsin D at day 1, and bacteria
were no longer detected thereafter (Figure 5C). Hence, IL-16 was
required to maintain T. whipplei localization within late phago-
somes. Second, the intracellular fate and localization of T. whipplei
were studied in bone marrow-derived macrophages (BMDM) from
IL16
2/2 mice. T. whipplei uptake by IL-16
2/2 and wild type (wt)
BMDMs was similar (Figure 6A, inset). In wt BMDMs, bacterial
replication was intense at days 9 and 12 post-infection (Figure 6A)
as published before [36] and similar to that observed in human
macrophages (see Figure 1). In IL-16
2/2 BMDMs, the bacterial
DNA copy number was 3.5 times lower (p,0.05) than that in wt
BMDMs at days 9 and 12 (Figure 6A), demonstrating that T.
whipplei replication was inhibited in the absence of IL-16. This
phenomenon was related to T. whipplei colocalization with
phagolysosomes. Specifically, in wt and IL-16
2/2 BMDMs, the
percentage of T. whipplei phagosomes that colocalized with
cathepsin D was higher in IL-16
2/2 BMDMs than in wt BMDMs
(7464% vs. 5666% at day 0, p,0.05; 5566% vs. 2162% at day
12, p,0.04) (Figure 6B and 6C). Taken together, these results
demonstrate that the microbicidal competence of macrophages
towards T. whipplei can be restored in the absence of IL-16.
Effect of IFNc on T. whipplei intracellular localization and
IL-16 production
Given that the absence of IL-16 is associated with T. whipplei
elimination by macrophages, and that impaired IFNc production
may be a cause of the delayed T. whipplei elimination in WD
patients [4], we looked for a connection between IL-16 and IFNc
in T. whipplei infection. To this end, macrophages were treated for
16 hours with recombinant IFNc prior to T. whipplei infection.
IFNc-treated macrophages internalized T. whipplei more efficiently
than untreated macrophages (p,0.05), but T. whipplei replication
was abolished at day 12 (p,0.05) (Figure 7A). The colocalization
of T. whipplei with Lamp-1 in untreated and IFNc-treated
macrophages was close to 80% at day 0 and did not change
thereafter (Figure 7B). In contrast, while the percentage of T.
whipplei colocalizing with cathepsin D decreased from 6666% to
1762% after 12 days in untreated cells, more than 85% of T.
whipplei phagosomes colocalized with cathepsin D in IFNc-treated
macrophages (Figure 7C). We then asked if IFNc stimulates T.
whipplei elimination by macrophages by interfering with IL-16
production. IL-16 production induced by T. whipplei was
completely inhibited when macrophages were pretreated with
IFNc (Table 1). Furthermore, IFNc inhibited the induction of T.
whipplei replication by IL-16 (Table 2). These data clearly show
that IFNc regulates IL-16 production, and IL-16 in turn mediates
T. whipplei replication.
Microarray analysis of IL-16
2/2 macrophages stimulated
with T. whipplei
As wt BMDMs infected with T. whipplei have been shown to
display an atypical activation program combining M2 polariza-
tion, a type I IFN response and apoptosis [36], host responses
towards T. whipplei in IL-16
2/2 BMDM were monitored using a
full genome microarray, and data were compared to those
previously reported [36] (GEO database at NCBI, accession
number GSE16180). After a six-hour stimulation with T. whipplei,
356 and 273 probes were significantly modulated in wt and IL-
16
2/2 BMDMs, respectively. Among them, only 42 probes were
similarly modulated in both wt and IL-16
2/2 BMDMs (Figure 8A
and Table S1). Next, the genes were annotated according to
functional classes. Gene Ontology (GO) biological processes at
level 3 did not detect major differences between wt and IL-16
2/2
BMDM responses to T. whipplei (Figure 8B). Indeed, the GO
terms of immune response (GO: 0006955), defense response (GO:
0006952), response to external stimulus (GO: 0009605), regulation
of biological process (GO: 0050789) and cytokine production (GO:
0001816) were significantly over-represented in both wt and IL-
16
2/2 BMDMs. In contrast, when GO biological processes were
analyzed at lower levels, functional differences were identified. For
example, analysis of GO biological processes at level 5 revealed 2
over-represented GO terms in wt BMDMs, different from the 13
over-represented GO terms in IL-16
2/2 BMDMs. Importantly,
among these 13 GO terms, 10 were linked to immune response
(Figure 8B). A closer analysis of GO biological processes at level 8
revealed that the regulation of the I-kB kinase/NF-kB cascade
(GO: 0043122) was over-represented in IL-16
2/2 BMDMs but
not in their wt counterparts (Figure 8B). These observations were
further confirmed by an analysis of over-represented genes
according to their transcription factors. Specifically, c-Rel and
STAT were over-represented in wt BMDMs (Figure 9A), in
accordance with recent data demonstrating that T. whipplei induces
type I IFN-dependent responses in these cells [36]. In contrast, in
IL-16
2/2 BMDMs, the main transcription factors regulated by T.
whipplei were NF-kB, CP2/LBP-1C/LSF and c-Rel (Figure 9B),
all involved in inflammatory responses. Taken together, these
results show that the activation programs induced by T. whipplei in
wt and IL-16
2/2 BMDMs are different, and that IL-16 might be
involved in macrophage activation. This effect was specific
because no significant terms were found between wt and IL-
16
2/2 BMDMs stimulated with lipolysaccharide (LPS). Using the
FatiGO Compare tool, 11,235 and 12,107 features were
significantly modulated in wt and IL-16
2/2 BMDMs, respectively.
The large majority (9121) of them were common to both wt and
IL-16
2/2 BMDMs (Figure S2).
Discussion
We describe here a previously unreported ability of IL-16 to
modulate anti-bacterial defenses. IL-16 inhibited T. whipplei killing
by inhibiting the maturation of bacterial phagosomes into
phagolysosomes. The intracellular fate of T. whipplei differed
dramatically between monocytes and macrophages. In monocytes,
IL-16 and Phagosome Maturation
PLoS ONE | www.plosone.org 6 October 2010 | Volume 5 | Issue 10 | e13561Figure 5. Effect of anti-IL-16 Abs on T. whipplei fate in macrophages. Macrophages were treated with or without anti-IL-16 blocking Abs for
18 hours, incubated with T. whipplei for 4 hours, washed to removeunphagocytosed bacteria andincubated for additional time periods in the presence
of blocking Abs. (A) T. whipplei uptake (inset) and replication were assessed by determining the bacterial DNA copy number by qPCR. The results are
expressed as the mean 6 SEM of four independent experiments performed in triplicate. (B) The intracellular localization of T. whipplei within
macrophages treated with anti-IL-16 Abs was assessed by indirect immunofluorescence and laser scanning microscopy at day 1. Scale bars represent
5 mm. (C) The percentage of T. whipplei that colocalized with cathepsin D or Lamp-1, respectively, was determined. More than 300 phagosomes were
examined per experimental condition, and the results are expressed as the mean 6 SEM of three independent experiments. p,0.05.
doi:10.1371/journal.pone.0013561.g005
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PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13561Figure 6. T. whipplei fate in IL-16
2/2 BMDM. BMDMs from wt and IL-16
2/2 mice were infected with T. whipplei similarly to the infection of human
macrophages. (A) T. whipplei uptake (inset) and replication were determined by qPCR. The results are expressed as the mean 6 SEM of four
independent experiments performed in triplicate. (B) The intracellular localization of T. whipplei within wt (left panel) and IL-16
2/2 (right panel)
BMDMs was assessed by indirect immunofluorescence and laser scanning microscopy at day 12. Scale bars represent 5 mm. (C) The percentage of T.
whipplei that colocalized with Lamp-1 or cathepsin D, respectively, was determined. More than 300 phagosomes were examined per experimental
condition, and the results are expressed as the mean 6 SEM of three independent experiments. The colocalization of T. whipplei (red) with cathepsin
D (green) appears as yellow; the colocalization of T. whipplei with Lamp-1 (blue) appears as purple; and the colocalization of T. whipplei with Lamp-1/
cathepsin D appears as white. p,0.05.
doi:10.1371/journal.pone.0013561.g006
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by the presence of Lamp-1 and cathepsin D. In macrophages, a
large number of bacteria were eliminated in an early phase, but
the remaining bacteria survived and intensively replicated in a late
phase. Similar results were obtained in a Brucella infection model,
in which the majority of bacteria were eliminated, while only few
bacteria survived and then replicated within a suitable compart-
ment [37]. When T. whipplei organisms replicated, they were
localized in late phagosomes harboring Lamp-1 but devoid of
cathepsin D, suggesting a blockage of phagosome-lysosome fusion.
We have also found that IL-16 inhibits the ability of both
human monocytes and macrophages to eliminate T. whipplei. First,
adding exogenous IL-16 to monocytes induced T. whipplei
replication and increased bacterial replication in macrophages as
published before [6]. Second, blocking IL-16 Abs induced T.
whipplei elimination as published before [6]. Third, T. whipplei
replicated in murine BMDMs, whereas bacterial replication was
inhibited in BMDMs from IL-16
2/2 mice. The effect of IL-16 on
the microbicidal responses of monocytes and macrophages cannot
be attributed to a deactivation effect similar to that induced by IL-
10 known to stimulate C. burnetii replication within macrophages
[38]. Indeed, IL-10 was unable to induce T. whipplei replication in
monocytes or to increase T. whipplei replication in macrophages
(Figure S3). On the other hand, the effect of IL-16 on T. whipplei
replication was specific since IL-16 had no effect on C. burnetii
replication (Figure S4). These results indicate that IL-16
specifically favors T. whipplei replication.
The inhibition of T. whipplei elimination by IL-16 was likely
related to the inhibited phagosome-lysosome fusion. In IL-16-
treated monocytes and macrophages, T. whipplei resided in late
phagosomes unable to fuse with lysosomes. Blocking IL-16 by
specific Abs led to T. whipplei elimination within phagolysosomes.
In mouse BMDMs that did not express IL-16, T. whipplei were also
eliminated in phagolysosomes. The effect of IL-16 on the
maturation of T. whipplei phagosomes was specific because IL-10
did not affect T. whipplei localization within phagolysosomes in
monocytes or that within late phagosomes in macrophages
Figure 7. Effect of exogenous IFNc on T. whipplei fate in
macrophages. Macrophages were treated with rhIFNc (500 UI/ml) and
then infected with T. whipplei (50 bacteria/cell). (A) T. whipplei uptake
(inset) and replication were determined by qPCR. The results are
expressed as the mean 6 SEM of four independent experiments
performed in triplicate. (B, C) The intracellular localization of T. whipplei
within IFNc-treated macrophages was assessed by indirect immunoflu-
orescence and laser scanning microscopy. The percentage of T. whipplei
that colocalized with Lamp-1 (B) or cathepsin D (C) was determined.
More than 300 phagosomes were examined per experimental
condition, and the results are expressed as the mean 6 SEM of five
independent experiments. p,0.05.
doi:10.1371/journal.pone.0013561.g007
Table 1. Effect of IFNc on IL-16 secretion
a.
IFNc 2 +
T. whipplei 2 + 2 +
IL-16 secretion 8.265 7006101 ,6.2 ,6.2
aMacrophages were pre-treated with or without rhIFNc (500 UI/ml) for 16 hours
and then infected with T. whipplei (50 bacteria/cell). Supernatants were
collected after 48 hours and assayed for the presence of IL-16 by
immunoassay. The results are expressed as the mean 6 SEM (pg/ml) of three
independent experiments performed in triplicate.
doi:10.1371/journal.pone.0013561.t001
Table 2. Effect of IFNc on IL-16-stimulated replication of
T. whipplei
a.
control IL-16 IL-16+IFNc
T. whipplei DNA copies (610
3) 28.662.1 63.465.5 0
aMacrophages were pretreated with or without rhIL-16 (10 ng/ml) for 16 hours,
infected with T. whipplei (50 bacteria/cell) in the absence or presence of rhIFNc,
washed to discard unphagocytosed bacteria and incubated for nine days in
the absence or presence of IFNc. Bacterial DNA copies were quantified by
qPCR at day 9. The results are expressed as the mean 6 SEM of four
independent experiments performed in triplicate.
doi:10.1371/journal.pone.0013561.t002
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localization of mycobacteria within early phagosomes [29] and to
increase the capacity of C. burnetii to traffic into a non-mature late
phagosome [32,33]. In addition, IL-16 specifically controlled T.
whipplei phagosome conversion because IL-16 had no effect on
latex bead and C. burnetii (Figure S4) trafficking. Cytokines such
as IFNc, IL-4 and IL-13 have been described to induce or inhibit
autophagy. Specifically, IFNc has been shown to re-route the
phagosome conversion pathway towards the autophagy pathway
[39]. We demonstrated that the effect of IL-16 on the intracellular
localization of T. whipplei was not associated with a re-routing of
the phagosome conversion pathway towards the autophagosome
pathway because p62, a marker for autophagosomes [35], did not
colocalize with T. whipplei.
The mechanisms elicited by IL-16 that enable T. whipplei
replication by blocking the late endosome stage were not related to
defective recruitment of several molecules involved in phagosome
conversion and phagolysosome biogenesis. It has been demon-
strated that cytokines such as IL-6 and IL-12 specifically affect the
expression of the GTPases Rab5 and Rab7, which are essential for
membrane trafficking events leading to phagosome-lysosome
fusion [40]. IFNc also selectively induces Rab5a synthesis [41].
We showed here that IL-16 did not affect the transcription of
either Rab5 or Rab7 (Figure S6). IL-16 might also inhibit the
fusion of T. whipplei phagosomes with lysosomes by modulating the
protein level of cathepsin D present on macrophages. Our results
clearly showed that IL-16 did not affect the protein expression of
cathepsin D or Lamp-1 (Figure S6). IFNc has been demonstrated
to affect the abundance, recruitment and phosphorylation of
several proteins involved in phagosome conversion [28] and to
affect Rab prenylation [41]. We therefore hypothesize that IL-16
might also affect post-transduction events in molecules engaged in
phagolysosome biogenesis. Note that cathepsin D and Lamp-1
arrive at lysosomes via different trafficking routes. Lamp-1 is
delivered to late endosomes and concentrates in lysosomes
whereas cathepsin D is delivered to late endosomes via the
mannose-6-phosphate receptor. We cannot exclude that IL-16
affects specifically one of these routes. An another hypothesis is
that IL-16 acts on T. whipplei replication and phago-lysosome
fusion by favoring a faster maturation of monocytes into
macrophages since IL-16 has been described to accelerate
differentiation of monocytes into macrophages [6].
Although IL-16 is considered a Th1-related cytokine [18], our
data suggest that IL-16 may also behave as a Th2-related cytokine.
In accordance with this hypothesis, IL-16 has been shown to
activate Stat-6, which is known to play a role in the polarization of
CD4
+ T cells to the Th2 phenotype [42]. Consequently, we
assumed that an imbalance between IL-16 and IFNc was likely to
occur in our case. First, IFNc induced both the elimination of T.
whipplei by macrophages in a dose-dependent manner (Table S2)
and phagosome conversion to phagolysosomes. Second, IFNc
inhibited both IL-16 production by macrophages and IL-16-
stimulated T. whipplei replication. It is likely that IFNc stimulates
the microbicidal response of macrophages towards T. whipplei by
impairing the IL-16 pathway.
To further investigate the downstream effectors of IL-16, we
analyzed the transcriptomic response to T. whipplei in IL-16
2/2
macrophages using a whole genome array and previouly reported
data [36]. In the absence of IL-16, the expression of 273 probes
was modulated by T. whipplei. The great majority of these probes
were not affected by T. whipplei in macrophages expressing IL-16.
This response was different from that to LPS treatment, in which
most modulated genes were common to macrophages with and
without IL-16 expression. The analysis of GO biological processes
revealed the enrichment of 13 GO terms linked to immune
response. Specifically, there was over-representation of the I-kB
kinase/NF-kB cascade. This finding is in agreement with our
recent publication in which the activation of transduction
pathways by T. whipplei involves a detrimental type I IFN signaling
pathway and a poor NF-kB response [36]. In the absence of IL-16,
we speculate that the activation of macrophages by T. whipplei
might favor the NF-kB pathway instead of the type 1 IFN
pathway. As a consequence, we can assume that IL-16 does not
Figure 9. Transcription factors activated by T. whipplei in
BMDMs. BMDMs were stimulated with T. whipplei for six hours and
host responses were analyzed using whole genome microarrays.
Significantly over-represented transcription factors involved in the
transcriptional responses of T. whipplei-stimulated wt (A) and IL-16
2/2
(B) BMDMs were determined using the Fatiscan tool.
doi:10.1371/journal.pone.0013561.g009
Figure 8. Analysis of transcriptional responses of BMDMs to T. whipplei. BMDMs were stimulated with T. whipplei (50 bacteria/cell) for six
hours and host responses were analyzed using whole genome microarrays. (A) Significant features were compared between wt (blue) and IL-16
2/2
(green) BMDMs and represented by a Venn diagram. Common significant features are displayed in grey. (B) Significantly over-represented GO
biological processes in T. whipplei-stimulated wt (blue) and IL-16
2/2 (green) BMDM were determined by applying the two-tailed Fisher’s exact test
(p,0.05).
doi:10.1371/journal.pone.0013561.g008
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NF-kB pathway were modulated in IL-16
2/2 BMDMs stimulated
with T. whipplei suggesting a partial effect of IL-6 on macrophages
polarization. Second, the effect of IL-16 on T. whipplei-stimulated
response was specific because the transcriptional response induced
by LPS were similar in wt and IL-16
2/2 BMDMs.
In conclusion, this study demonstrates for the first time that IL-
16 induces T. whipplei replication by blocking the normal
conversion of T. whipplei phagosomes into phagolysosomes. Our
data also suggest that IL-16 inhibits the fusion of T. whipplei
phagosomes with lysosomes by inducing a macrophage activation
program that causes the IFNc and NF-kB pathways to become
essential to the elimination of T. whipplei. These results might
explain why IFNc was efficient for the treatment of refractory
WD. They also suggest that IL-16 blockade by IFNc, specific Abs
or RNAi might contribute to the therapeutic elimination of T.
whipplei in WD patients.
Methods
T. whipplei culture
The Twist-Marseille strain of T. whipplei (CNCM I-2202) was
cocultured with HEL cells (CCL-37; American Type Culture
Collection) and purified as previously described [34]. Bacteria
were counted by Gimenez staining and indirect immunofluores-
cence, and their viability was assessed using the LIVE/DEAD
BacLight Bacterial Viability Kit (Molecular Probes).
Cell culture
Peripheral blood mononuclear cells (PBMCs) were isolated from
leukopacks (Etablissement Franc ¸ais du Sang) by Ficoll gradient
(MSL, Eurobio). Monocytes were then isolated using CD14
+
columns as recommended by the manufacturer (Miltenyi Biotec).
More than 95% of the cells were CD14
+ monocytes as determined
by flow cytometry. Macrophages were derived from monocytes by
a seven-day culture in RPMI 1640 containing human AB serum:
more than 95% of cells were considered as macrophages since they
expressed CD68 as determined by flow cytometry. Monocytes and
macrophages (10
5 cells/assay) were incubated in flat-bottom 24-
well plates containing glass coverslips for immunofluorescence
experiments. Then, they were infected with T. whipplei for four
hours, washed to remove unphagocytosed bacteria and incubated
for designated periods in RPMI 1640 containing 10% fetal calf
serum (FCS) [6]. In some experiments, rhIL-16 (10 ng/ml) [6],
rhIL-10 (10 ng/ml) or rhIFNc (500 UI/ml) (R&D Systems) was
added to monocytes and macrophages 18 hours prior to infection.
Endogenous IL-16 was neutralized using 1 mg/ml anti-IL-
16 mAbs (R&D Systems) as previously described [6].
BMDMs were generated from 6- to 8-week-old IL-16
2/2
C57BL/6 and littermate controls, as previously described [43].
Briefly, mice were euthanized by cervical dislocation, and bone
marrow was flushed out from femurs and tibias. Bone marrow
progenitors were seeded in Petri dishes in RPMI supplemented
with 10% FCS, 2 mM L-glutamine, 100 UI/ml penicillin and
100 mg/ml streptomycin supplemented with 15% L929 cell
supernatant and allowed to differentiate for seven days [44].
Differentiated BMDMs were seeded (10
5 cells/well containing a
glass coverslip for immunofluorescence analysis) in 24-well tissue
culture plates in RPMI medium.
Ethics Statement
All animal experiments followed the guiding principles of
animal care and use defined by the Conseil Scientifique du Centre
de Formation et de Recherche Experimental Me ´dico-Chirurgical
(CFREMC) with the rules of De ´cret Nu 87-848 of 10/19/1987
and were approved by the ethics board of the university at which
the experiments were performed (Faculte ´d eM e ´decine de la
Timone, Experimentation permit number 13.385).
Quantitative real-time PCR (qPCR)
Cells were lyzed, and DNA was extracted using the QIAamp
DNA Mini Kit (Qiagen). PCR was performed using the
LightCycler-FastStart DNA Master SYBR Green system (Roche)
with primers specific for the T. whipplei 16S-23S ribosomal
intergenic spacer region (tws3f and tws4r) as previously described
[45]. The sequences of primers for T. whipplei were as follows:
ccggtgacttaacctttttggaga (left primer) and tcccgaggcttatcgcagattg
(right primer). In each PCR run, a standard curve was generated
using serial dilutions ranging from 10 to 10
8 copies of the
intergenic spacer region, and the results were calculated using the
LightCycler 5.32 software (LC-Run version 5.32, Roche).
Colocalization experiments
Cells (10
5 cells/assay) were infected with T. whipplei (50
bacteria/cell) for four hours, extensively washed to discard
unphagocytosed bacteria and then incubated for different time
periods before fixation in 3% paraformaldehyde. Fixed cells were
permeabilized with 0.1% Triton X-100 or 0.1% saponin, and
immunofluorescence labeling was performed according to stan-
dard procedures [46]. Polyclonal rabbit and monoclonal mouse
anti-T. whipplei Abs were generated in our laboratory. Rat and
mouse Abs specific for Lamp-1 (clone 1D4B and H4A3) were
purchased from DSHB (Iowa, USA). Rabbit Ab specific for
cathepsin D was a gift from Dr. S. Kornfeld (Washington
University School of Medicine, St. Louis, MO) and Rabbit Ab
specific for p62 was a gift from S. Meresse (Centre d’Immunologie
de Marseille Luminy, Marseille, France). Secondary Alexa Abs,
goat anti-mouse IgG conjugated with Alexa 488, goat anti-rat IgG
and anti-rabbit IgG coupled with Alexa 555 were purchased from
Invitrogen. In human monocytes and macrophages, the coloca-
lization of T. whipplei with Lamp-1 or cathepsin D was studied
using the couples mouse Lamp-1 Abs with rabbit anti-T. whipplei
Abs and rabbit anti-cathepsin D Abs with mouse anti-T. whipplei
Abs, respectively. In BMDMs, the combination of mouse anti-T.
whipplei Abs, rat anti-Lamp-1 Abs and rabbit anti-cathepsin D Abs
was used to directly assess the colocalization of T. whipplei with
both Lamp-1 and cathepsin D. Cells were then examined by laser
scanning microscopy using a confocal microscope (Leica TCS
SP5, Heidelberg, Germany) with a 63X/1.32-0.6 oil objective and
an electronic Zoom 1.5X. Optical sections of fluorescent images
were collected at 0.15-mm intervals using Leica Confocal Software
and processed using Adobe Photoshop V7.0.1 software. At least
100 cells were examined for each experimental condition. The
results are expressed as the percentage of bacteria that colocalized
with fluorescent markers. Cells were selected as follows: 25
microscope fields, with at least four cells per field containing at
least three phagosomes were randomly selected. More than 300
phagosomes were examined per experimental condition.
Microarray analysis
BMDMs were infected with T. whipplei (50 bacteria/cell) for six
hours, and total RNA was extracted using the RNeasy Mini Kit
(Qiagen). The quality and the quantity of prepared RNA were
assessed using the 2100 Bioanalyzer (Agilent Technologies).
Sample labeling and hybridization were performed according to
the manufacturer’s recommendations (One-Color Microarray-
Based Gene Expression Analysis). Briefly, labeled cDNA was
synthesized using the Low RNA Input Fluorescent Amplification
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3-labeled CTP. Hybridizations of 4X44k Mouse Whole Genome
microarrays (Agilent Technologies) were performed in triplicate
for 17 hours at 65uC using the In situ Hybridization Kit Plus
(Agilent Technologies). Slides were scanned at a 5-mm resolution
by a G2505B DNA microarray scanner (Agilent Technologies),
and images were analyzed with the Agilent Feature Extractor
Software 9.5.1.1. Global normalization by trimmed means was
applied to raw datasets using the Excel software (Microsoft). A
threshold-free functional profiling of significant features of the
microarray was applied to avoid any loss of information as
previously described [47]. Significant features were selected by
applying the Student’s t test to the input data with a p value,0.01.
GO annotation and enrichment of GO biological process were
performed with the freely available online tools FatiGO Search
and Fatiscan (http://babelomics.bioinfo.cipf.es/). The two-tailed
Fisher’s exact test was used to determine functional classes of genes
significantly over-represented or under-represented (p,0.05).
GEO Database
All data are MIAME compliant and the raw data have been
deposited in a MIAME compliant database (GEO). All transcrip-
tional profile files are available in the GEO database at NCBI
(accession number GSE20210).
Immunoassays
Macrophages were treated with or without rhIFNc for 16 hours
and then infected with T. whipplei (50 bacteria/cell) for 48 hours in
the presence or absence of IFNc. Cell supernatants were assessed
for the presence of IL-16 by immunoassay (R&D Systems). The
sensitivity of kits is about 6.2 pg/ml.
Statistical analysis
Results are expressed as means 6 SEM and were analyzed by
the non-parametric Mann-Whitney U test. Differences were
considered significant when p,0.05.
Supporting Information
Figure S1 Effect of IL-16 on the intracellular localization of
latex beads. Macrophages were pretreated with rhIL-16 for
18 hours, incubated with latex beads (dilution 1/5000, Sigma
Aldrich) for 4 hours, washed to remove unphagocytosed beads and
incubated for additional time periods. The intracellular localiza-
tion of the latex beads was analyzed by indirect immunofluores-
cence and laser scanning microscopy. The percentage of beads
that colocalized with (A) Lamp-1 or (B) cathepsin D was
determined. More than 300 phagosomes were examined per
experimental condition, and the results are expressed as the mean
6 SEM of two independent experiments.
Found at: doi:10.1371/journal.pone.0013561.s001 (0.56 MB TIF)
Figure S2 Analysis of transcriptional responses of BMDMs to
LPS. BMDMs were stimulated with LPS (100 ng/ml) for six
hours, and host responses were analyzed by microarrays. Gene
expression values were normalized by trimmed means. Significant
features were then compared between wt (blue) and IL-162/2
(green) BMDMs and represented by a Venn diagram. Common
significant features are displayed in grey.
Found at: doi:10.1371/journal.pone.0013561.s002 (0.58 MB TIF)
Figure S3 Effect of IL-10 on T. whipplei replication. Monocytes
and macrophages were pretreated with or without rhIL-10
(10 ng/ml) for 18 hours, incubated with T. whipplei (50 bacteria/
cell) for 4 hours, washed to remove unphagocytosed bacteria and
incubated for additional time periods. T. whipplei uptake (inset) and
replication in monocytes (A) and macrophages (B) were assessed by
determining the bacterial DNA copy number by qPCR. The
results are expressed as the mean 6 SEM of four independent
experiments.
Found at: doi:10.1371/journal.pone.0013561.s003 (0.53 MB TIF)
Figure S4 Effect of IL-16 on C. burnetii replication and
intracellular localization. Human macrophages were pretreated
with or without rhIL-16 (10 ng/ml) for 18 hours, incubated with
C. burnetii (200 bacteria/cell) for 4 hours, washed to remove
unphagocytosed bacteria and incubated for additional time
periods. (A) C. burnetii replication was assessed by determining
the bacterial DNA copy number by qPCR. The results are
expressed as the mean 6 SEM of three independent experiments.
(B) The intracellular localization of C. burnetii within IL-16 treated
cells was assessed by indirect immunofluorescence and laser
scanning microscopy. The percentage of organisms that coloca-
lized with lysosomes (Lamp-1 and cathepsin D) was determined.
More than 150 phagosomes were examined per experimental
condition, and the results are expressed as the mean 6 SEM of
three independent experiments.
Found at: doi:10.1371/journal.pone.0013561.s004 (0.52 MB TIF)
Figure S5 Effect of IL-10 on T. whipplei intracellular localiza-
tion. Monocytes (A, B) and macrophages (C, D) were pretreated
with or without IL-10 (10 ng/ml) for 18 hours, incubated with T.
whipplei for 4 hours (50 bacteria/cell), washed to remove
unphagocytosed bacteria and incubated for additional time
periods. The intracellular localization of T. whipplei within IL-10-
treated cells was assessed by indirect immunofluorescence and
laser scanning microscopy. The percentage of organisms that
colocalized with Lamp-1 (A and C) or cathepsin D (B and D) was
determined. More than 300 phagosomes were examined per
experimental condition, and the results are expressed as the mean
6 SEM of five independent experiments.
Found at: doi:10.1371/journal.pone.0013561.s005 (0.76 MB TIF)
Figure S6 IL-16 does not modulate molecules involved in
phagosome conversion. Macrophages treated with rhIL-16 (10
ng/ml) for different time periods were lysed and RNA was
extracted using the QIAamp RNA Mini Kit (Qiagen). cDNA was
synthesized from 1 mg of total RNA using SuperScript II RNase H
reverse transcriptase (Invitrogen). Specific primers for each gene
were designed using the Primer3Plus software (http://frodo.wi.
mit.edu/primer3/). The primer sequences were as follows: for
Rab5, cgggccaaatactggaaata (left primer) and aggacttgcttgcctctgaa
(right primer); for Rab7, ggccttctacagaggtgcag (left primer) and
ccggtcattcttgtccagtt (right primer); for b-actin used as an internal
control, ggaaatcgtgcgtgacatta (left primer) and aggaaggaaggctg-
gaagag (right primer). PCR was performed using Hotstart Taq
polymerase (Qiagen) following the manufacturer’s recommenda-
tions. PCR products were electrophoresed through a 1% agarose
gel containing ethidium bromide. Data were acquired with a Gel
Doc 2000 (BioRad), and gene expression was normalized to b-
actin. The figure is representative of three experiments. (B)
Macrophages were stimulated with or without rhIL-16 (10 ng/ml)
for 16 hours and washed with ice-cold PBS. Western blotting was
performed as previously described (Al Moussawi et al. 2010). In
brief, cells were lysed in ice-cold RIPA buffer containing protease
inhibitor (Complete, Roche) and phosphatase inhibitor (Phospho-
stop, Roche) cocktails. After clearing, cell lysates were loaded onto
12% SDS polyacrylamide gels, electrophoresed and transferred
onto nitrocellulose membranes (Millipore). The membranes were
incubated with primary Abs directed against a-tubulin (Cell
Signaling), Lamp-1 (H4A3, Abcam) or cathepsin D and then
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rabbit or anti-mouse IgG (Pierce). The blots were then revealed
using the Immobilon Western Chemiluminescent HRP substrate
(Millipore). Each blot is a representative of three independent
experiments.
Found at: doi:10.1371/journal.pone.0013561.s006 (0.68 MB TIF)
Table S1 Transcripts significantly induced by T. whipplei in both
wt and IL-162/2 BMDMs.
Found at: doi:10.1371/journal.pone.0013561.s007 (0.08 MB
DOC)
Table S2 IFNc induces T. whipplei elimination in a dose-
dependent manner. Macrophages were treated with different
concentrations of rhIFNc and infected with T. whipplei (50
bacteria/cell). Bacterial replication was assessed by determining
the bacterial DNA copy number by qPCR and cell viability was
determined using Trypan blue exclusion. The results are expressed
as the mean 6 SEM of four independent experiments performed
in triplicate.
Found at: doi:10.1371/journal.pone.0013561.s008 (0.03 MB
DOC)
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